Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome
Zeber-Lubecka, Natalia, Kulecka, Maria, Ambrozkiewicz, Filip, Paziewska, Agnieszka, Goryca, Krzysztof, Karczmarski, Jakub, Rubel, Tymon, Wojtowicz, Wojciech, Mlynarz, Piotr, Marczak, Lukasz, Tomecki,Language:
english
Journal:
Gut Microbes
DOI:
10.1080/19490976.2016.1215805
Date:
July, 2016
File:
PDF, 1.30 MB
english, 2016